| Names | |
|---|---|
| IUPAC name (1R,4aR,4bS,7R,10aR)-7-ethenyl-1,4a,7-trimethyl-3,4,4b,5,6,9,10,10a-octahydro-2H-phenanthrene-1-carboxylic acid | |
Other names
| |
| Identifiers | |
3D model (JSmol) | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C20H30O2 | |
| Molar mass | 302.458 g·mol−1 |
| Appearance | solid |
| Density | 1.05 g/cm3 |
| Melting point | 248 °C |
| Boiling point | 413.2 °C |
| poorly soluble | |
| Hazards | |
| Flash point | 198.7±23.4 °C |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Sandaracopimaric acid is a naturally occurring diterpenoid, a class of tricyclic organic compounds derived from plant resins. [1] It is characterized by its role as a plant metabolite and exhibits potential anti-inflammatory properties. [2] [3]
Sandaracopimaric acid features a carboxylic acid group at the position 1 and a vinyl group at the position 7 on a phenanthrene backbone. The compound is a member of the pimaric acids group and also the larger group of resin acids.
The acid is an isomer of 4-epi-sandaracopimaric acid, pimaric acid, continentalic acid, and some other acids. The compound is chiral, with the levorotatory form ((-)-sandaracopimaric acid) being the predominant natural enantiomer.
The structure was identified in 1960 by O. E. Edwards. [4] The total synthesis of the natural enantiomer was achieved in 1968 by A. Afonso et al. [5] The process has 13 steps and starts with testosterone acetate. [6]
Sandaracopimaric acid was first isolated in the early 20th century by Henry and by Tschirch and Wolff from the resin of the sandarac tree, native to North Africa. [7] [4] It has since been identified in various plant species, including: Ramalina hierrensis , Pinus armandii , Juniperus rigida , Wollemia nobilis , and many others, where it serves as a defense against herbivores. [8]
Sandaracopimaric acid is also found in other resins and terrestrial plants, contributing to their chemical defense mechanisms.
Sandaracopimaric acid demonstrates anti-inflammatory effects, notably by reducing contractions in phenylephrine-induced pulmonary arteries. [9] It acts as an inhibitor of GABA receptors and has been studied for potential therapeutic applications in inflammation-related conditions. [3] [10] [11]
Research suggests roles in plant-herbivore interactions and possible antimicrobial properties, though human clinical applications remain exploratory.
The acid is commercially available for research as a reference standard and is used in studies of diterpenoid biosynthesis and bioactivity. [12]